Effect of topiroxostat in patients with diabetic nephropathy and gout or hyperuricemia: fact or fallacy
Sign Up to like & getrecommendations! Published in 2018 at "Clinical and Experimental Nephrology"
DOI: 10.1007/s10157-018-1540-z
Abstract: To the Editor, We have read the research article “Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo-controlled, parallel-group study (UPWARD… read more here.
Keywords: patients diabetic; gout hyperuricemia; nephropathy gout; hyperuricemia ... See more keywords